Strata Critical Medical, Inc.
NASDAQ:SRTAAirlines, Airports & Air Services
-$0.03 today
- Market cap
- $443.03M
- Beta
- 2.20
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.60
Volume 0.99M
Average 0.91M
SRTA Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Strata Critical Medical, Inc.NASDAQ: SRTA
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities rises 462.6% from a year ago
Other non-current liabilities stood at $17.19M at the end of Q1 FY2026, up 462.6% from a year earlier and down 27.2% from the prior quarter. Over 3 fiscal years it compounded at +38.1% a year.
Context
- Other non-current liabilities amounted to 5.2% of total assets at the end of Q1 FY2026, up 4.0 pp from a year earlier.
- Other non-current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +462.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 23.6M USD
- Year-over-year change
- +306.4%
- 4-year CAGR
- -6.9%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.6M | +306.4% |
| FY2024 | 2024-12-31 | 5.81M | +17.1% |
| FY2023 | 2023-12-31 | 4.96M | -44.7% |
| FY2022 | 2022-12-31 | 8.96M | -71.5% |
| FY2021 | 2021-09-30 | 31.45M | — |
Other Non-current Liabilities vs competitors
How SRTA compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +462.6% is the 2nd highest of 11, against a peer median of -0.6%.
- Other non-current liabilities amounts to 5.2% of total assets for SRTA, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $56.67M USD | +58.7% | +7.0% | 12.6% | |
| Mar 2026 | $41.9M USD | +1.9% | +9.4% | 10.9% | |
| Mar 2026 | $20.57M USD | +12.7% | +79.8% | 3.7% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | $17.19M USD | +462.6% | +38.1% | 5.2% |
| Mar 2026 | $12.46M USD | +751.0% | +79.3% | 2.6% | |
| Mar 2026 | $2.67M USD | -17.1% | +123.5% | 0.4% | |
| Apr 2026 | $1.54M USD | -3.2% | -25.0% | 0.1% | |
| Mar 2026 | $1.32M USD | -97.4% | -90.7% | 0.2% | |
| Mar 2026 | $1.29M USD | -33.1% | -40.6% | 0.2% | |
| Mar 2026 | £793.04K GBP | -85.6% | — | 0.7% | |
| Feb 2026 | $518K USD | +3.6% | -35.1% | 0.1% | |
| Peer median (excluding SRTA) | — | -0.6% | +7.0% | 0.6% | |
Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.6M | 41.34M | 27.87M | 18.38M | 30.97M |
| Short-term Investments | 279.37M | 150.74M | 138.26M | 108.76M | 30.26M |
| Net Receivables | 5.55M | 10.88M | 21.01M | 21.59M | 39.96M |
| Inventory | 547K | 0 | 0 | 0 | 0 |
| Other Current Assets | 83K | 3.09M | 19.12M | 12.02M | 25M |
| Total Current Assets | 294.95M | 218.13M | 206.26M | 160.74M | 126.19M |
| Property, Plant & Equipment (Net) | 2.76M | 19.73M | 26.38M | 39.79M | 39.55M |
| Goodwill | 13.33M | 39.45M | 40.37M | 41.05M | 88.21M |
| Intangible Assets | 24.42M | 46.37M | 20.52M | 13.65M | 47.5M |
| Long-term Investments | 200K | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 232K | 1.36M | 1.4M | 1.44M | 24.02M |
| Total Non-current Assets | 40.94M | 106.9M | 88.68M | 95.93M | 199.28M |
| Total Assets | 335.88M | 325.03M | 294.94M | 256.68M | 325.47M |
| Account Payables | 6.37M | 16.54M | 0 | 0 | 19.14M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 6.85M | 6.66M | 0 |
| Other Current Liabilities | 5.98M | 6.71M | 23.86M | 12.77M | 0 |
| Total Current Liabilities | 12.78M | 26.61M | 35.49M | 22.73M | 19.79M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 451K | 185K | 348K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 31.45M | 8.96M | 4.96M | 5.81M | 23.6M |
| Total Non-current Liabilities | 31.73M | 23.93M | 25.15M | 12.01M | 26.61M |
| Total Liabilities | 44.51M | 50.54M | 60.64M | 34.74M | 46.4M |
| Common Stock | 7K | 7K | 7K | 7K | 7K |
| Retained Earnings | (76.42M) | (103.68M) | (159.75M) | (186.9M) | (145.55M) |
| Accumulated OCI | (898K) | 2.29M | 3.96M | 1.75M | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 291.37M | 274.49M | 234.3M | 221.94M | 279.07M |
| Total Debt | 716K | 18.33M | 24.53M | 9.32M | 3.31M |
| Net Debt | (1.88M) | (23.01M) | (3.35M) | (9.06M) | (27.66M) |
Strata Critical Medical, Inc.
NASDAQ:SRTA
Intrinsic Alpha fair value
Locked
Current Price
$4.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.